• Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Источник: Buzz FX / 07 фев 2025 02:06:10   America/Chicago


    Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Regeneron Pharmaceuticals, Inc.
    Read more...
Опубликовать